Verano Holdings (VRNO) Total Current Liabilities (2021 - 2026)

Verano Holdings' (VRNO) quarterly Total Current Liabilities came in at $118.9 million in Q1 2026, down 29.07% year-on-year from $167.6 million in Q1 2025, and down 15.22% on a QoQ basis from $140.3 million in Q4 2025.

Verano Holdings (VRNO) Total Current Liabilities (2021 - 2026) Analysis & Trends

Verano Holdings (VRNO) has 6 years of Total Current Liabilities data on file, last reported at $118.9 million in Q1 2026.

  • On a quarterly basis, Total Current Liabilities fell 29.07% year-over-year to $118.9 million in Q1 2026; TTM through Mar 2026 was $118.9 million, a 29.07% decrease from a year earlier, with the FY2025 full-year figure at $140.3 million, down 30.94% from the prior year.
  • Total Current Liabilities for Q1 2026 stood at $118.9 million, down from $140.3 million in the prior quarter.
  • Over the last five years, Total Current Liabilities for VRNO reached as high as $586.8 million in Q2 2022 and fell as low as $118.9 million in Q1 2026.
  • Historically, Total Current Liabilities has averaged $310.4 million across 5 years, with a median of $356.4 million in 2023.
  • Across the five-year window, Total Current Liabilities advanced 23.58% in 2024 and slumped 67.06% in 2025, its largest moves.
  • Year by year, Total Current Liabilities stood at $386.6 million in 2022, then advanced by 6.61% to $412.2 million in 2023, then plunged by 50.72% to $203.1 million in 2024, then slumped by 30.94% to $140.3 million in 2025, then dropped by 15.22% to $118.9 million in 2026.
  • Per Business Quant data, the three most recent Total Current Liabilities figures were $118.9 million in Q1 2026, $140.3 million in Q4 2025, and $143.4 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 6.56 Bn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.53 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 2.05 Bn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 18.06 Bn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 599.10 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - 13.17 Bn
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 6.81 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 831.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 1.66 Bn
10 Verano Holdings 2.02 Bn 1.94 Bn 98.98 Mn 118.91 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 118.91 Mn
Dec 31, 2025 140.26 Mn
Sep 30, 2025 143.41 Mn
Jun 30, 2025 147.83 Mn
Mar 31, 2025 167.64 Mn
Dec 31, 2024 203.11 Mn
Sep 30, 2024 435.38 Mn
Jun 30, 2024 360.59 Mn
Mar 31, 2024 414.98 Mn
Dec 31, 2023 412.19 Mn
Sep 30, 2023 352.30 Mn
Jun 30, 2023 348.32 Mn
Mar 31, 2023 363.39 Mn
Dec 31, 2022 386.65 Mn
Sep 30, 2022 384.20 Mn
Jun 30, 2022 586.78 Mn
Dec 31, 2021 470.52 Mn